Related Experiment Video
Updated: Apr 16, 2026

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
Published on: May 4, 2015
Myocardial infarct size and mortality depend on the time of day-a large multicenter study
Stephane Fournier1, Patrick Taffé2, Dragana Radovanovic3
1Department of Cardiology, University Hospital Center (CHUV), Lausanne, Switzerland.
Insights
This study reveals a daily pattern in heart attack size and patient survival, independent of symptom duration. Heart attack onset time impacts outcomes, suggesting its use in prognosis.
Area of Science:
- Cardiology
- Chronobiology
- Public Health
Background:
- Previous research indicates variable circadian patterns in ST-Elevation Myocardial Infarction (STEMI) ischemic burden.
- Conflicting results necessitate further investigation into daily variations in STEMI outcomes.
Purpose of the Study:
- To investigate the circadian variation in myocardial infarction size and in-hospital mortality.
- To analyze these variations in a large, multicenter registry of STEMI patients.
Main Methods:
- Retrospective analysis of the AMIS Plus Swiss registry (1999-2013).
- Peak creatine kinase (CK) used as a proxy for myocardial infarction size.
- Polynomial-harmonic regression modeled associations between peak CK, mortality, and symptom onset time.
Main Results:
- A significant 24-hour harmonic pattern was observed for both peak CK and in-hospital mortality.
- Peak myocardial infarction size was highest for symptom onset at 23:00 and lowest at 11:00.
- In-hospital mortality risk was highest for symptom onset at 00:00 and lowest at 12:00, independent of ischemic time.
Conclusions:
- Confirmed a circadian pattern in peak CK and in-hospital mortality for STEMI patients treated with primary angioplasty.
- This circadian variation is independent of total ischemic time.
- Recommends incorporating symptom onset time as a prognostic factor in myocardial infarction management.
Background:
Different studies have shown circadian variation of ischemic burden among patients with ST-Elevation Myocardial Infarction (STEMI), but with controversial results. The aim of this study was to analyze circadian variation of myocardial infarction size and in-hospital mortality in a large multicenter registry.
Methods:
This retrospective, registry-based study was based on data from AMIS Plus, a large multicenter Swiss registry of patients who suffered myocardial infarction between 1999 and 2013. Peak creatine kinase (CK) was used as a proxy measure for myocardial infarction size. Associations between peak CK, in-hospital mortality, and the time of day at symptom onset were modelled using polynomial-harmonic regression methods.
Results:
6,223 STEMI patients were admitted to 82 acute-care hospitals in Switzerland and treated with primary angioplasty within six hours of symptom onset. Only the 24-hour harmonic was significantly associated with peak CK (p = 0.0001). The maximum average peak CK value (2,315 U/L) was for patients with symptom onset at 23:00, whereas the minimum average (2,017 U/L) was for onset at 11:00. The amplitude of variation was 298 U/L. In addition, no correlation was observed between ischemic time and circadian peak CK variation. Of the 6,223 patients, 223 (3.58%) died during index hospitalization. Remarkably, only the 24-hour harmonic was significantly associated with in-hospital mortality. The risk of death from STEMI was highest for patients with symptom onset at 00:00 and lowest for those with onset at 12:00.
Discussion:
As a part of this first large study of STEMI patients treated with primary angioplasty in Swiss hospitals, investigations confirmed a circadian pattern to both peak CK and in-hospital mortality which were independent of total ischemic time. Accordingly, this study proposes that symptom onset time be incorporated as a prognosis factor in patients with myocardial infarction.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis I: Introduction

